Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc.

SBFM | NASDAQ
Chart Builder DCF Calculator
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.94
+$0.03 (+3.30%)
After-hours: Sep 21, 2026, 7:59 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-5.98M -5.13M -4.51M -26.74M -12.44M -2.78M
Depreciation & Amortization
332.07K 223.53K 149.15K 25.16K 12.74K 14.07K
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a
Other Working Capital
497.11K -1.02M -94.39K 276.87K -2.88K 1.72K
Other Non-Cash Items
1.76M -2.24M n/a 18.32M 10.7M 2.16M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.45M -5.38M -4.42M 3.15M -108.8K -42.64K
Operating Cash Flow
-5.33M -12.53M -8.78M -5.25M -1.83M -657.3K
Capital Expenditures
-174.49K -2.32M -788.1K -305K -2 -1.19K
Cash Acquisitions
n/a n/a n/a -14.35M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -322.26K -573.9K -77.64K n/a n/a
Investing Cash Flow
-836.31K -2.32M -656.15K -14.62M n/a -1.19K
Debt Repayment
n/a 347.94K -125.99K -1.93M 2.9M 1.61M
Common Stock Repurchased
n/a -3.14M -541.14K -99K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -1.97M n/a n/a
Financial Cash Flow
4.75M 9.29M 3.43M 39.47M 2.9M 1.61M
Net Cash Flow
-563.22K -6.61M -5.53M 19.78M 1.06M 949.39K
Free Cash Flow
-5.51M -14.85M -9.56M -5.55M -1.83M -658.49K
Adj. Free Cash Flow
-5.51M -14.85M -9.56M -5.55M -1.83M -658.49K
Maintenance CapEx
-102.22K -1.65M n/a n/a n/a n/a
Growth CapEx
-72.27K -669.21K -788.1K -305K -2 -1.19K
Owner Earnings
-5.43M -14.18M -8.78M -5.25M -1.83M -657.3K

© 2026 bestshares.com. All rights reserved.